Howard Hughes Medical Institute’s Voya Financial VOYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-35,591
Closed -$1.31M 120
2017
Q2
$1.31M Sell
35,591
-7,933
-18% -$289K 0.24% 63
2017
Q1
$1.65M Buy
43,524
+7,808
+22% +$314K 0.3% 64
2016
Q4
$1.4M Buy
35,716
+5,126
+17% +$181K 0.32% 60
2016
Q3
$882K Buy
30,590
+3,876
+15% +$106K 0.23% 72
2016
Q2
$661K Buy
26,714
+3,450
+15% +$106K 0.22% 76
2016
Q1
$693K Buy
23,264
+823
+4% +$24.9K 0.15% 73
2015
Q4
$828K Sell
22,441
-9,618
-30% -$381K 0.13% 78
2015
Q3
$1.24M Buy
32,059
+3,642
+13% +$160K 0.23% 58
2015
Q2
$1.32M Buy
28,417
+2,534
+10% +$114K 0.28% 66
2015
Q1
$1.12M Buy
25,883
+10,358
+67% +$436K 0.15% 65
2014
Q4
$658K Buy
15,525
+5,550
+56% +$222K 0.18% 77
2014
Q3
$390K Buy
9,975
+3,595
+56% +$136K 0.09% 91
2014
Q2
$232K Buy
6,380
+1,426
+29% +$51K 0.04% 85
2014
Q1
$180K Sell
4,954
-126
-2% -$4.47K 0.03% 92
2013
Q4
$179K Buy
5,080
+381
+8% +$12.6K 0.03% 98
2013
Q3
$137K Buy
+4,699
New +$141K 0.02% 106

Other funds holding VOYA

Howard Hughes Medical Institute's VOYA Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of Voya Financial (VOYA) in Q3 2017, closing a stake of 35,591 shares — an estimated $1.31M sold.

Howard Hughes Medical Institute first reported a position in VOYA in Q3 2013 and held it in 16 quarters. The position peaked at $1.65M in Q1 2017. 338 funds tracked by Wall St. Rank hold VOYA as of Q3 2017.

  • Howard Hughes Medical Institute reported no remaining Voya Financial position as of Q3 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 35,591 Voya Financial shares in Q3 2017, an estimated $1.31M.
  • Howard Hughes Medical Institute first reported a position in Voya Financial in Q3 2013 and held it in 16 quarters.
  • Howard Hughes Medical Institute's Voya Financial position peaked at $1.65M in Q1 2017.
  • 338 funds tracked by Wall St. Rank held Voya Financial as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.